Chemotherapy of cytomegalovirus infections. Further results on intraperitoneal infection of Ehrlich ascites tumor mice with viruses of low virulence in vivo: MCMV-Smith, adenovirus 2, RSV-Long and rhinoviruses.
D000227:Adenine Nucleotides / Q000627:therapeutic use; D000256:Adenoviridae / Q000187:drug effects*; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003587:Cytomegalovirus / Q000187:drug effects*; D005260:Female; D007065:Idoxuridine / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D011134:Polysaccharides / Q000627:therapeutic use; D012136:Respiratory Syncytial Viruses / Q000187:drug effects*; D012229:Rhinovirus / Q000187:drug effects*; D018139:Simplexvirus / Q000187:drug effects; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000227:Adenine Nucleotides; D007211:Indoles; D011134:Polysaccharides; D013882:Thiosemicarbazones; D007065:Idoxuridine